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Abstract
Background: For over 20 years, the National Health Service in England has run a system of national planning for
highly specialised healthcare services. The aim is to ensure that very rare diseases are treated, and very complex
procedures performed, in only a few centres, each of which maintains a volume high enough to maintain excellent
outcomes. The commissioning strategy for the provision of these national services in England is strongly
centralising. Centralising does however create a duty to ensure that patients distant from the treatment centres are
not thereby disadvantaged. The commissioning process ensures sufficient capacity to treat the entire national
caseload of clinically eligible patients. The aim of this paper is to apply the Systematic Component of Variation
(SCV) to study access to services commissioned by the National Specialised Commissioning Team (NSCT) in
England. The discussion focuses on the potential explanations for a high level of systematic variation between areas
and on the use of the SCV to support the monitoring and development of these nationally commissioned services.
Method: Data from nationally commissioned services for the year ending 2011 were received from treating
hospital. Mid year age and sex appropriate population estimates were then obtained to provide denominator data.
Data were analysed at the geographic level of strategic health authority.
Results: 30 services met all requirements for analysis. There is no apparent relationship between SCV and number
of locations from which the service is provided. On inspection high SCV is more common among recently
commissioned services.
Discussion: The importance of the SCV lies in its ability to support the development of highly specialised services.
Once the random variation has been accounted for, the reasons for a systematic component can be explored.
While no absolute cut- off exists, the SCV can be used to gauge and explore services that are potentially not
covering the national caseload. The reason for a high SCV may not be immediately apparent; thus the SCV can aid
those responsible for commissioning the service to seek potential explanations and identify improvements.
Conclusion: We have reviewed spatial variation in access to a set of highly specialised services in England. On
inspecting our results, we believe that they suggest that equity of access can usually be achieved at about five
years after establishing a service, and this is not dependent, within the geography of England, on the number of
centres designated.
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Introduction
For over 20 years, the National Health Service in England
has run a system of national planning for highly specia-
lised healthcare services. In its current form, the National
Specialised Commissioning Team (NSCT) commissions a
set of around 60 highly specialised services for the Na-
tional Health Service in England [1]. Generally speaking,
these are services that affect fewer than 500 people across
England or involve services where fewer than 500 highly
specialised procedures are undertaken each year. The aim
is to ensure that very rare diseases are treated, and very
complex procedures performed, in only a few centres,
each of which maintains a volume high enough to main-
tain excellent outcomes. Hence the commissioning
strategy is strongly centralising. Nationally commis-
sioned services are funded from a central budget so ac-
cess to the service is free to the patient and to the local
health economy.
Centralising does however create a duty to ensure that
patients distant from the treatment centres are not
thereby disadvantaged. The commissioning process
ensures sufficient capacity to treat the entire national
caseload of clinically eligible patients.
Since there will inevitably be some random variation
in access to services between areas, a statistical measure
of variation is needed to identify if the variation is more
(or less) than a random effect. The Systematic Component
of Variation (SCV) performs well [2,3] and has previously
been used to study spatial equity of access to local services
in the National Health Service in England [4,5]. The SCV
metric partitions observed variation between areas into a
random component, using a Poisson assumption, and a
systematic component.
The aim of this paper is to apply the SCV to study ac-
cess to services commissioned by the NSCT in England.
Access is a complex construct; in this paper we use ser-
vice use as a measure for access. The discussion focuses
on the potential explanations for a high level of system-
atic variation between areas and the use of the SCV to
support the monitoring and development of these na-
tionally commissioned services. There is a prior expect-
ation that geographical variation in access will decrease
as services are taken into national commissioning and
that the longer a service has been commissioned nation-
ally the more uniform the coverage, with the expectation
that they would have a lower SCV. Without national
commissioning local budget holders often refuse funding
(and hence access) to these high cost services; national
commissioning removes this barrier. This inequity,
known in England as ‘postcode lottery’ is an important
factor in ministers’ decisions to take a service into na-
tional commissioning. A national service also attracts
publicity among doctors and patients, increasing the
likelihood of referral to an expert centre.
Method
Numerator data (counts of patients, caseload or proce-
dures as appropriate) for the year ended 31 March 2011
were submitted by treating hospitals from local data-
bases. ‘Patients’ are patients new to the service seen for
the first time during the year in question. ‘Caseload’ is
patients seen face-to-face by the service during the year
ended 31 March 2011; each patient is only counted
once. The data were coded by Primary Care Trust of
residence. Data for transplants were kindly supplied by
NHS Blood and Transplant as they hold these data.
Denominator data (mid year population estimates for
2010) were obtained from the Office for National Statis-
tics [6]. For conditions affecting only children or only
adults or only one sex appropriate age- and sex- specific
denominator populations were used.
Data were analysed at the geographical level of Stra-
tegic Health Authority. The Strategic Health Authorities
cover diverse populations and divide England into ten
areas with total populations ranging from 2.6 million to
7.8 million.
With ten units of analysis it was thought that a service
with a numerator count less than 30 would have data too
sparse for sensible analysis. For this reason these services
were excluded from the analysis. In addition services that
were unable to produce a full dataset from each centre
where the service was delivered were also excluded. Ser-
vices where the available data did not meet Poisson
assumptions (e.g. consisted of total attendances, including
repeat attendance by the same individual) were also
excluded. Services for young people in secure mental fa-
cilities represents an example of this.
The start date for the service is defined as the date on
which national commissioning of the service com-
menced. The number of locations is defined as the num-
ber of places (cities) in which the service is provided, but
London is counted as one location even if there are two
or more providers in London.
The calculation for the SCV is easily executed using a
spreadsheet, which is available from the corresponding
author on request.
Results
Of the 51 national services commissioned at 31 March
2010, 10 were excluded because the numerator for ana-
lysis was less than 30. A further 11 services were
excluded either for lack of a full dataset from all centres,
or because the available data did not meet Poisson
assumptions. This left 30 services available for analysis.
Results are shown in the Table 1. There is no apparent
relationship between SCV and number of locations from
which the service is provided. Eleven services had an
SCV of 20 or more, of which 8 have been operating as
nationally commissioned services for 5 years or less.
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Discussion
The SCV gives an estimate of the relative systematic
component of variation between two areas by subtract-
ing the random component of variance from the esti-
mated of the total variance [3]. Therefore the calculation
of the SCV gives an estimation of amount variation for a
given set of standardised rates. This allows a comparison
between a set of such rates to be made; in this paper the
set is defined by services that are commissioned by the
NSCT. Unlike a p-value which has an accepted statistical
value, the SCV has no absolute interpretation but in pre-
vious work a cut-off of 16 has been suggested in one
paper as indicative of high variability [5]. In the present
study, we took an arbitrary value of 20 to indicate a high
level of systematic variation.
There are several potential explanations for a high
level of systematic variation between areas.
The first is that disease incidence or prevalence is not
uniform. This may apply to very rare diseases which
are strongly genetic. Neurofibromatosis Type 1 may be
an example of this. Approximately 50% of cases of
Neurofibromatosis Type 1 have an identifiable inherited
cause [7], but these cases often occur in geographical
grouping.
Table 1 Geographic variation in nationally commissioned services ordered by year service commissioned






Choriocarcinoma 1984 Patients 131 4 9.2 1.1 2
Specialist paediatric liver disease 1985 Caseload 3405 25 671.9 100.4 3
Severe combined immune deficiency 1993 Patients 36 0 6.6 0.0 2
Elective liver transplant (adult) 1995 Transplants 371 1 12.0 6.2 6
Elective liver transplant (child) 1995 Transplants 49 11 8.2 0.0 3
Severe intestinal failure 1998 Caseload 318 70 17.8 0.5 2
Amyloidosis 1999 Caseload 409 4 11.3 4.9 1
Pseudomyxoma peritonei surgery 2000 Patients 111 5 5.1 1.0 2
Pulmonary thrombendarterectomy 2000 Patients 106 9 4.5 0.6 1
Lung transplant (adult) 2002 Transplants 135 3 5.9 1.3 5
Heart transplant (adult) 2002 Transplants 71 8 3.5 0.5 5
Heart transplant (child) 2002 Transplants 31 8 6.6 0.0 2
Epidermolysis bullosa 2002 Caseload 1102 17 44.2 8.8 2
Pancreas transplant 2004 Transplants 171 27 10.4 1.4 5
Lysosomal storage disorder (adult) 2005 Caseload 917 0 27.2 19.2 4
Primary malignant bone tumour 2005 Patients 495 13 20.0 6.0 5
Lysosomal storage disorder (child) 2005 Caseload 553 16 102.4 26.8 4
Complex tracheal surgery 2006 Patients 51 15 9.7 1.0 1
Congenital hyperinsulinism 2006 Caseload 458 34 95.4 8.7 2
Pulmonary hypertension (child) 2007 Caseload 279 8 48.4 17.1 1
Severe obsessive compulsive disorder 2007 Patients 116 50 6.7 0.2 1
Gender identity development 2009 Patients 132 5 21.9 6.2 1
Complex Ehlers Danlos syndrome 2009 Patients 107 26 4.9 0.4 2
Complex neurofibromatosis type I 2009 Caseload 700 74 32.2 1.3 2
Chronic pulmonary aspergillosis 2009 Caseload 225 268 31.0 0.0 1
Xeroderma pigmentosum 2010 Caseload 49 8 2.0 0.2 1
Biedl Bardet syndrome (adult) 2010 Caseload 111 11 4.4 0.5 2
Complex neurofibromatosis type II 2010 Caseload 513 20 16.0 2.2 4
Cryopyrin associated periodic syndrome 2010 Caseload 37 31 1.7 0.0 1
Neuromyelitis optica 2010 Caseload 193 132 13.5 0.2 2
Table ordered by start date for national commissioning. Services with SCV 20 or greater are shown in bold.
‘Patients’ means patients seen for the first time by the service; ‘caseload’ means patients (new and old) seen face-to-face by the service during the reporting
period. ‘Transplants’ means the number of transplants.
‘Number’ is the number of patients, caseload or transplants. ‘Rate per million’ is the highest (lowest) rate per million among the 10 geographical areas analysed.
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Secondly, a newly developed service will in its early
years tend to treat the local catchment first. Variation will
decrease as the service develops full national coverage.
Three of the 17 services commissioned before 2006 show
high systematic variation compared to 8 of the 13 services
commissioned in 2006 or later. This suggests that the act
of national commissioning provides a mechanism to re-
duce variation in access to specialised services. Almost all
services taken into national commissioning arrangements
have been running before national commissioning and
attempting to achieve national coverage, but the high
variation at onset and in the early years suggests very
patchy coverage prior to national commissioning.
Thirdly, patients remote from the treatment centre may
be disadvantaged in their access to highly specialised ser-
vices. Patients with very rare conditions almost always ex-
press a willingness to travel any distance to see treatment
teams who are thoroughly knowledgeable about their
condition, particularly if the visits are not too frequent
(annual review or one-off procedures). Nevertheless dis-
tance effects may occur either because of the burden of
travel, or because of lesser awareness among clinicians in
remote centres of either the disease itself or of the bene-
fits of treatment. The problem of awareness is likely to
apply particularly to the newly commissioned services.
This mechanism will also apply if referral criteria for
the highly specialised service are not completely clear.
We believe that this is the mechanism for the inequity
in the services for severe intestinal failure. In this service
subjective judgements are required among referring clini-
cians about degrees of severity and hence about which
patients to refer.
Finally variation may be a data artefact if the quality of
data are poor. Returns from treatment centres for nationally
commissioned datasets are, unlike routine NHS data
sources, almost all made from bespoke databases and vali-
dated by the treating clinicians. Hence we believe that the
quality of the numerator data used in this study is high.
Application of the SCV
The importance of the SCV lies in its ability to support
the development of highly specialised services. Once the
random variation (which will exist to a certain extent in
the majority of services) has been accounted for, the rea-
sons for a systematic component can be explored. While
no absolute cut- off exists, it can be used to gauge and
explore services that are potentially not covering the na-
tional caseload. The reason for a high SCV may not be
immediately apparent thus the SCV can aid those respon-
sible for commissioning the service to seek potential
explanations and indentify improvements. The calculation
of the SCV should be encouraged by those responsible for
commissioning highly specialised services and incorpo-
rated the into evaluation process. Policy responses to high
SCV include education and awareness campaigns in low
access areas, outreach clinics and occasionally develop-
ment of a new expert centre.
It is not always obvious what statistic to count if the
aim is to ensure equity of access. Indeed equity of out-
come is what we really want to achieve. However that
data are very difficult to capture. Within equity of ac-
cess, we may choose to count all contacts with the ser-
vice, or only those which result in a face-to-face
consultation, or only those in which the patient turns
out, after assessment, to meet the service definition.
Limitations
There are potential limitations around the statistical
measurement of the SCV as it has no conventionally
accepted cut off point. Therefore all we can state is the
size of the ratio rather than an absolute measure. The
SCV is not currently routinely used and therefore may
be less widely accepted as a routine measure of spatial
equity. However with greater awareness of its potential
application this situation may change.
Conclusion
We have reviewed spatial variation in access to a set of
highly specialised services in England. On inspecting our
results we believe that they suggest that equity of access
can usually be achieved at about five years after establishing
a service, and this is not dependent, within the geography
of England, on the number of centres designated.
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